Bank of Montreal
FATE icon

Bank of Montreal’s Fate Therapeutics FATE Stock Holding History

Bank of Montreal’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,405
Closed -$269K – 4067
2021
Q1 		$269K Sell
3,405
-8,109
-70% -$777K ﹤0.01% 2981
2020
Q4 		$1.29M Buy
11,514
+8,191
+246% +$509K ﹤0.01% 2071
2020
Q3 		$138K Sell
3,323
-1,665
-33% -$58.1K ﹤0.01% 2916
2020
Q2 		$181K Buy
+4,988
New +$149K ﹤0.01% 2783
2020
Q1 		– Sell
-7,656
Closed -$150K – 4274
2019
Q4 		$150K Buy
7,656
+3,067
+67% +$48.7K ﹤0.01% 3307
2019
Q3 		$71K Buy
4,589
+211
+5% +$4.04K ﹤0.01% 3466
2019
Q2 		$89K Buy
4,378
+4,368
+43,680% +$78.7K ﹤0.01% 3403
2019
Q1 		$0 Sell
10
-1,544
-99% -$24.4K ﹤0.01% 4435
2018
Q4 		$20K Buy
1,554
+510
+49% +$7.11K ﹤0.01% 3640
2018
Q3 		$17K Buy
1,044
+15
+1% +$177 ﹤0.01% 3758
2018
Q2 		$12K Buy
1,029
+349
+51% +$3.85K ﹤0.01% 3905
2018
Q1 		$7K Sell
680
-2,320
-77% -$22.2K ﹤0.01% 3855
2017
Q4 		$18K Buy
3,000
+2,983
+17,547% +$13.3K ﹤0.01% 3621
2017
Q3 		$0 Buy
+17
New +$58 ﹤0.01% 4208
2017
Q1 		– Sell
-13
Closed – – 4036
2016
Q4 		$0 Sell
13
-1
-7% -$3 ﹤0.01% 4087
2016
Q3 		$0 Sell
14
-271
-95% -$658 ﹤0.01% 4073
2016
Q2 		$0 Buy
285
+278
+3,971% +$504 ﹤0.01% 4151
2016
Q1 		$0 Sell
7
-5
-42% -$10 ﹤0.01% 4250
2015
Q4 		$0 Sell
12
-19
-61% -$80 ﹤0.01% 4285
2015
Q3 		$0 Buy
31
+8
+35% +$55 ﹤0.01% 4030
2015
Q2 		$0 Sell
23
-1,977
-99% -$11.8K ﹤0.01% 3975
2015
Q1 		$10K Buy
+2,000
New +$9.91K ﹤0.01% 3491

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's FATE Position: Q2 2021 in Review

Bank of Montreal sold out of Fate Therapeutics (FATE) in Q2 2021, closing a stake of 3,405 shares — an estimated $269K sold.

Bank of Montreal first reported a position in FATE in Q1 2015 and held it in 22 quarters. The position peaked at $1.29M in Q4 2020. 272 funds tracked by Wall St. Rank hold FATE as of Q2 2021.

  • Bank of Montreal reported no remaining Fate Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 3,405 Fate Therapeutics shares in Q2 2021, an estimated $269K.
  • Bank of Montreal first reported a position in Fate Therapeutics in Q1 2015 and held it in 22 quarters.
  • Bank of Montreal's Fate Therapeutics position peaked at $1.29M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.